- Home
- MARPS vs POAI Comparison
MARPS vs POAI Comparison
Compare MARPS & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MARPS
- POAI
- Stock Information
- Founded
- MARPS 1956
- POAI 2002
- Country
- MARPS United States
- POAI United States
- Employees
- MARPS N/A
- POAI N/A
- Industry
- MARPS Oil & Gas Production
- POAI Industrial Specialties
- Sector
- MARPS Energy
- POAI Health Care
- Exchange
- MARPS Nasdaq
- POAI Nasdaq
- Market Cap
- MARPS 7.5M
- POAI 8.9M
- IPO Year
- MARPS N/A
- POAI N/A
- Fundamental
- Price
- MARPS $4.41
- POAI $0.89
- Analyst Decision
- MARPS
- POAI Hold
- Analyst Count
- MARPS 0
- POAI 1
- Target Price
- MARPS N/A
- POAI N/A
- AVG Volume (30 Days)
- MARPS 243.7K
- POAI 101.5K
- Earning Date
- MARPS 01-01-0001
- POAI 08-12-2025
- Dividend Yield
- MARPS 8.20%
- POAI N/A
- EPS Growth
- MARPS N/A
- POAI N/A
- EPS
- MARPS 0.36
- POAI N/A
- Revenue
- MARPS $1,036,019.00
- POAI $1,729,269.00
- Revenue This Year
- MARPS N/A
- POAI $486.27
- Revenue Next Year
- MARPS N/A
- POAI $65.50
- P/E Ratio
- MARPS $12.12
- POAI N/A
- Revenue Growth
- MARPS N/A
- POAI 24.17
- 52 Week Low
- MARPS $3.34
- POAI $0.55
- 52 Week High
- MARPS $7.90
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- MARPS 48.76
- POAI 38.00
- Support Level
- MARPS $4.20
- POAI $0.85
- Resistance Level
- MARPS $6.46
- POAI $0.91
- Average True Range (ATR)
- MARPS 0.89
- POAI 0.06
- MACD
- MARPS -0.07
- POAI -0.00
- Stochastic Oscillator
- MARPS 16.11
- POAI 4.12
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.